| REGISTERED NUMBER: |
| MSK Ingredients & Equipment Limited |
| Financial Statements for the Period 1st October 2024 to 31st December 2025 |
| REGISTERED NUMBER: |
| MSK Ingredients & Equipment Limited |
| Financial Statements for the Period 1st October 2024 to 31st December 2025 |
| MSK Ingredients & Equipment Limited (Registered number: 09759885) |
| Contents of the Financial Statements |
| for the period 1st October 2024 to 31st December 2025 |
| Page |
| Company Information | 1 |
| Balance Sheet | 2 |
| Notes to the Financial Statements | 3 |
| MSK Ingredients & Equipment Limited |
| Company Information |
| for the period 1st October 2024 to 31st December 2025 |
| DIRECTORS: |
| SECRETARY: |
| REGISTERED OFFICE: |
| REGISTERED NUMBER: |
| AUDITORS: |
| Chartered Accountants |
| Statutory Auditor |
| Regent's Court |
| Princess Street |
| Hull |
| East Yorkshire |
| HU2 8BA |
| MSK Ingredients & Equipment Limited (Registered number: 09759885) |
| Balance Sheet |
| 31st December 2025 |
| 2025 | 2024 |
| Notes | £ | £ | £ | £ |
| FIXED ASSETS |
| Investments | 4 |
| CURRENT ASSETS |
| Debtors | 5 |
| Cash at bank |
| CREDITORS |
| Amounts falling due within one year | 6 |
| NET CURRENT LIABILITIES | ( |
) | ( |
) |
| TOTAL ASSETS LESS CURRENT LIABILITIES |
| CAPITAL AND RESERVES |
| Called up share capital |
| Share premium |
| Retained earnings |
| The financial statements were approved by the Board of Directors and authorised for issue on |
| MSK Ingredients & Equipment Limited (Registered number: 09759885) |
| Notes to the Financial Statements |
| for the period 1st October 2024 to 31st December 2025 |
| 1. | STATUTORY INFORMATION |
| MSK Ingredients & Equipment Limited is a |
| 2. | ACCOUNTING POLICIES |
| Basis of preparing the financial statements |
| Preparation of consolidated financial statements |
| The financial statements contain information about MSK Ingredients & Equipment Limited as an individual company and do not contain consolidated financial information as the parent of a group. The company is exempt under Section 399(2A) of the Companies Act 2006 from the requirements to prepare consolidated financial statements. |
| Related party exemption |
| The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group. |
| Investments in subsidiaries |
| Investments in subsidiary undertakings are recognised at cost. |
| Financial instruments |
| The company's group loans payable meet the definition of a basic financial instrument, so they are originally recognised at the transaction price. |
| Taxation |
| Taxation for the period comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. |
| Current or deferred taxation assets and liabilities are not discounted. |
| Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date. |
| Deferred tax |
| Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date. |
| Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the period end and that are expected to apply to the reversal of the timing difference. |
| Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. |
| 3. | EMPLOYEES AND DIRECTORS |
| The average number of employees during the period was NIL (2024 - NIL). |
| MSK Ingredients & Equipment Limited (Registered number: 09759885) |
| Notes to the Financial Statements - continued |
| for the period 1st October 2024 to 31st December 2025 |
| 4. | FIXED ASSET INVESTMENTS |
| Shares in |
| group |
| undertakings |
| £ |
| COST |
| At 1st October 2024 |
| and 31st December 2025 |
| NET BOOK VALUE |
| At 31st December 2025 |
| At 30th September 2024 |
| 5. | DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |
| 2025 | 2024 |
| £ | £ |
| Amounts owed by group undertakings |
| 6. | CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |
| 2025 | 2024 |
| £ | £ |
| Amounts owed to group undertakings |
| Other creditors |
| 7. | DISCLOSURE UNDER SECTION 444(5B) OF THE COMPANIES ACT 2006 |
| The Report of the Auditors was unqualified. |
| for and on behalf of |
| 8. | CONTINGENT LIABILITIES |
| The company has guaranteed long term liabilities due to the shareholders of the parent company. This is supported by fixed and floating charges over the assets of the company. The maximum amounts due under these agreements are €12,500,000 and £17,280,500. |
| 9. | ULTIMATE CONTROLLING PARTY |
| On 2nd October 2024, the entire share capital of this company was acquired by Inga Group Limited, a company registered in England and Wales and whose accounts are publicly available from Companies House, Crown Way, Cardiff, CF14 3UZ. |
| The company's ultimate parent undertaking is Axel Johnson Holding AB, a company registered in Sweden. |